What MK-677 is
MK-677 is a small-molecule, non-peptide agonist at the ghrelin/growth hormone secretagogue receptor. Unlike the peptide secretagogues, it is orally bioavailable, which is the property most often examined in the literature.
It is supplied as a laboratory research material. It is not a registered therapeutic good in Australia and is not supplied for human or veterinary use.
What the published research investigates
Published work covers receptor pharmacology, oral bioavailability and comparative studies against injectable secretagogue peptides.
Search the primary literature via the link below and read the papers directly rather than relying on supplier summaries.
Legal status in Australia
Materials on this site are supplied strictly for in-vitro laboratory research. They are not therapeutic goods, are not approved by the TGA for human use, and are not supplied for human or veterinary consumption.
Purchasers must be 18 or over and are responsible for handling, storing and disposing of research materials in line with their institution's requirements and applicable Australian law.
Nothing on this page is medical advice, a dosing protocol, or a claim of therapeutic benefit. It summarises what the published research literature investigates.
Common questions
No. It is a non-peptide small molecule that acts at the same receptor as the peptide secretagogues, which is why it appears alongside them in the research literature.
It is supplied as a research chemical for in-vitro laboratory use. It is not TGA-approved and is not sold for human or veterinary consumption.
Yes — every lot carries a batch-specific CoA with the HPLC chromatogram and analytical identity confirmation, available on request or via our batch verification tool.